Selected research
Industry Research
Cyclosporine API Industry Research Report 2026
Market perspective
The global Cyclosporine API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cyclosporine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cyclosporine API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cyclosporine API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cyclosporine API include Chemwerth Inc, Ckd Bio Corporation, Concord Biotech, Curia Global, Inc., Fishfa Biogenics, Manus Aktteva Biopharma LLP, Medisca, Novas International and Octagonchem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cyclosporine API market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cyclosporine API Market by Company
Chemwerth Inc
Ckd Bio Corporation
Concord Biotech
Curia Global, Inc.
Fishfa Biogenics
Manus Aktteva Biopharma LLP
Medisca
Novas International
Octagonchem
Fujian Kerui Pharmaceutical Co., Ltd.
Guangzhou Tosun Pharmaceutical Ltd
Ruibang
Cyclosporine API Segment by Type
Purity≥99%
Purity<99%
Cyclosporine API Segment by Application
Injection
Tablet
Capsule
Eye Drops
Others
Cyclosporine API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclosporine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyclosporine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclosporine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cyclosporine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cyclosporine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cyclosporine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity≥99%
- Purity<99%
Applications
- Injection
- Tablet
- Capsule
- Eye Drops
- Others
Companies covered
- Chemwerth Inc
- Ckd Bio Corporation
- Concord Biotech
- Curia Global, Inc.
- Fishfa Biogenics
- Manus Aktteva Biopharma LLP
- Medisca
- Novas International
- Octagonchem
- Fujian Kerui Pharmaceutical Co., Ltd.
- Guangzhou Tosun Pharmaceutical Ltd
- Ruibang
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cyclosporine API Market Size (2021-2032)
- 2.2.2 Global Cyclosporine API Sales (2021-2032)
- 2.2.3 Global Cyclosporine API Market Average Price (2021-2032)
- 2.3 Cyclosporine API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity≥99%
- 2.3.3 Purity<99%
- 2.4 Cyclosporine API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Injection
- 2.4.3 Tablet
- 2.4.4 Capsule
- 2.4.5 Eye Drops
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cyclosporine API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cyclosporine API Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Cyclosporine API Revenue of Manufacturers (2021-2026)
- 3.4 Global Cyclosporine API Average Price by Manufacturers (2021-2026)
- 3.5 Global Cyclosporine API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cyclosporine API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cyclosporine API, Product Type & Application
- 3.8 Global Manufacturers of Cyclosporine API, Established Date
- 3.9 Global Cyclosporine API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chemwerth Inc
- 4.1.1 Chemwerth Inc Company Information
- 4.1.2 Chemwerth Inc Business Overview
- 4.1.3 Chemwerth Inc Cyclosporine API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chemwerth Inc Cyclosporine API Product Portfolio
- 4.1.5 Chemwerth Inc Recent Developments
- 4.2 Ckd Bio Corporation
- 4.2.1 Ckd Bio Corporation Company Information
- 4.2.2 Ckd Bio Corporation Business Overview
- 4.2.3 Ckd Bio Corporation Cyclosporine API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Ckd Bio Corporation Cyclosporine API Product Portfolio
- 4.2.5 Ckd Bio Corporation Recent Developments
- 4.3 Concord Biotech
- 4.3.1 Concord Biotech Company Information
- 4.3.2 Concord Biotech Business Overview
- 4.3.3 Concord Biotech Cyclosporine API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Concord Biotech Cyclosporine API Product Portfolio
- 4.3.5 Concord Biotech Recent Developments
- 4.4 Curia Global, Inc.
- 4.4.1 Curia Global, Inc. Company Information
- 4.4.2 Curia Global, Inc. Business Overview
- 4.4.3 Curia Global, Inc. Cyclosporine API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Curia Global, Inc. Cyclosporine API Product Portfolio
- 4.4.5 Curia Global, Inc. Recent Developments
- 4.5 Fishfa Biogenics
- 4.5.1 Fishfa Biogenics Company Information
- 4.5.2 Fishfa Biogenics Business Overview
- 4.5.3 Fishfa Biogenics Cyclosporine API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Fishfa Biogenics Cyclosporine API Product Portfolio
- 4.5.5 Fishfa Biogenics Recent Developments
- 4.6 Manus Aktteva Biopharma LLP
- 4.6.1 Manus Aktteva Biopharma LLP Company Information
- 4.6.2 Manus Aktteva Biopharma LLP Business Overview
- 4.6.3 Manus Aktteva Biopharma LLP Cyclosporine API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Manus Aktteva Biopharma LLP Cyclosporine API Product Portfolio
- 4.6.5 Manus Aktteva Biopharma LLP Recent Developments
- 4.7 Medisca
- 4.7.1 Medisca Company Information
- 4.7.2 Medisca Business Overview
- 4.7.3 Medisca Cyclosporine API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Medisca Cyclosporine API Product Portfolio
- 4.7.5 Medisca Recent Developments
- 4.8 Novas International
- 4.8.1 Novas International Company Information
- 4.8.2 Novas International Business Overview
- 4.8.3 Novas International Cyclosporine API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Novas International Cyclosporine API Product Portfolio
- 4.8.5 Novas International Recent Developments
- 4.9 Octagonchem
- 4.9.1 Octagonchem Company Information
- 4.9.2 Octagonchem Business Overview
- 4.9.3 Octagonchem Cyclosporine API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Octagonchem Cyclosporine API Product Portfolio
- 4.9.5 Octagonchem Recent Developments
- 4.10 Fujian Kerui Pharmaceutical Co., Ltd.
- 4.10.1 Fujian Kerui Pharmaceutical Co., Ltd. Company Information
- 4.10.2 Fujian Kerui Pharmaceutical Co., Ltd. Business Overview
- 4.10.3 Fujian Kerui Pharmaceutical Co., Ltd. Cyclosporine API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Fujian Kerui Pharmaceutical Co., Ltd. Cyclosporine API Product Portfolio
- 4.10.5 Fujian Kerui Pharmaceutical Co., Ltd. Recent Developments
- 4.11 Guangzhou Tosun Pharmaceutical Ltd
- 4.11.1 Guangzhou Tosun Pharmaceutical Ltd Company Information
- 4.11.2 Guangzhou Tosun Pharmaceutical Ltd Business Overview
- 4.11.3 Guangzhou Tosun Pharmaceutical Ltd Cyclosporine API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Guangzhou Tosun Pharmaceutical Ltd Cyclosporine API Product Portfolio
- 4.11.5 Guangzhou Tosun Pharmaceutical Ltd Recent Developments
- 4.12 Ruibang
- 4.12.1 Ruibang Company Information
- 4.12.2 Ruibang Business Overview
- 4.12.3 Ruibang Cyclosporine API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ruibang Cyclosporine API Product Portfolio
- 4.12.5 Ruibang Recent Developments
5 Global Cyclosporine API Market Scenario by Region
- 5.1 Global Cyclosporine API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cyclosporine API Sales by Region: 2021-2032
- 5.2.1 Global Cyclosporine API Sales by Region: 2021-2026
- 5.2.2 Global Cyclosporine API Sales by Region: 2027-2032
- 5.3 Global Cyclosporine API Revenue by Region: 2021-2032
- 5.3.1 Global Cyclosporine API Revenue by Region: 2021-2026
- 5.3.2 Global Cyclosporine API Revenue by Region: 2027-2032
- 5.4 North America Cyclosporine API Market Facts & Figures by Country
- 5.4.1 North America Cyclosporine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cyclosporine API Sales by Country (2021-2032)
- 5.4.3 North America Cyclosporine API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cyclosporine API Market Facts & Figures by Country
- 5.5.1 Europe Cyclosporine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cyclosporine API Sales by Country (2021-2032)
- 5.5.3 Europe Cyclosporine API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cyclosporine API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cyclosporine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cyclosporine API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cyclosporine API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cyclosporine API Market Facts & Figures by Country
- 5.7.1 South America Cyclosporine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cyclosporine API Sales by Country (2021-2032)
- 5.7.3 South America Cyclosporine API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cyclosporine API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cyclosporine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cyclosporine API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cyclosporine API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cyclosporine API Sales by Type (2021-2032)
- 6.1.1 Global Cyclosporine API Sales by Type (2021-2032) & (t)
- 6.1.2 Global Cyclosporine API Sales Market Share by Type (2021-2032)
- 6.2 Global Cyclosporine API Revenue by Type (2021-2032)
- 6.2.1 Global Cyclosporine API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cyclosporine API Revenue Market Share by Type (2021-2032)
- 6.3 Global Cyclosporine API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cyclosporine API Sales by Application (2021-2032)
- 7.1.1 Global Cyclosporine API Sales by Application (2021-2032) & (t)
- 7.1.2 Global Cyclosporine API Sales Market Share by Application (2021-2032)
- 7.2 Global Cyclosporine API Revenue by Application (2021-2032)
- 7.2.1 Global Cyclosporine API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cyclosporine API Revenue Market Share by Application (2021-2032)
- 7.3 Global Cyclosporine API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cyclosporine API Value Chain Analysis
- 8.1.1 Cyclosporine API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cyclosporine API Production Mode & Process
- 8.2 Cyclosporine API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cyclosporine API Distributors
- 8.2.3 Cyclosporine API Customers
9 Global Cyclosporine API Analyzing Market Dynamics
- 9.1 Cyclosporine API Industry Trends
- 9.2 Cyclosporine API Industry Drivers
- 9.3 Cyclosporine API Industry Opportunities and Challenges
- 9.4 Cyclosporine API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst